非COVID-19手术患者因法国重症与中间监护病房暴露于疫情而导致的超额死亡
这项法国全国观察性研究纳入2019年1月1日至2020年12月31日所有非COVID-19手术患者,共1,870,515例、655家医院,2%死亡。以患者住院期间所在医院ICU/IMCU每日COVID-19患者占比定义疫情暴露,用多层模型嵌套三重差分估计标准化院内死亡率。与2019年相比,高暴露医院患者2020上半年标准化死亡率增加1%(95%CI 0.6-1.4%)、下半年增加0.4%(0-1%);高暴露较低或无暴露组上半年死亡风险更高(校正比值比之比1.56,95%CI 1.34-1.81),ICU/IMCU内(1.27,1.02-1.58)和之外(1.98,1.57-2.5)均升高,下半年较上半年有显著学习效应(0.76,0.58-0.99)。作者认为超额死亡主要发生在ICU/IMCU之外,提示手术患者获得重症监护的机会受限。
要点
- 法国655家医院1,870,515例非COVID-19手术患者中2%死亡,高暴露医院2020上半年标准化死亡率较2019年增加1%(95%CI 0.6-1.4%)。
- 高暴露较低或无暴露组,2020上半年死亡风险校正比值比之比1.56(95%CI 1.34-1.81)。
- 超额死亡在ICU/IMCU之外更明显(1.98,95%CI 1.57-2.5),ICU/IMCU内为1.27(95%CI 1.02-1.58)。
- 2020下半年较上半年出现显著学习效应(0.76,95%CI 0.58-0.99),标准化死亡率增幅降至0.4%(0-1%)。
适用人群与场景
- 2019年1月1日至2020年12月31日在法国655家医院接受手术的全部非COVID-19患者,共1,870,515例。
诊断标准与关键阈值
- 疫情暴露按患者住院期间同一医院ICU/IMCU床位中每日COVID-19患者占全部收治患者的比例定义,分为高暴露与低或无暴露组。
研究设计与关键结果
- 全国观察性研究纳入1,870,515例非COVID-19手术患者(655家医院),2%死亡。
- 与2019年相比,高暴露医院患者2020上半年标准化死亡率增加1%(95%CI 0.6-1.4%),下半年增加0.4%(0-1%)。
- 高暴露组较低或无暴露组,2020上半年死亡风险校正比值比之比1.56(95%CI 1.34-1.81)。
- 上述风险升高在ICU/IMCU内(1.27,95%CI 1.02-1.58)和ICU/IMCU之外(1.98,95%CI 1.57-2.5)均存在,ICU/IMCU之外更高。
- 2020下半年较上半年有显著学习效应(0.76,95%CI 0.58-0.99)。
- 作者结论认为显著超额死亡主要发生在ICU/IMCU之外,提示手术患者获得重症监护的机会受限。
证据类型、等级与局限
- 证据类型:全国观察性研究,采用多层模型嵌套三重差分分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为超额死亡主要发生在ICU/IMCU之外,提示疫情高峰期间手术患者获得重症监护的机会受限。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: The mobilization of most available hospital resources to manage coronavirus disease 2019 (COVID-19) may have affected the safety of care for non-COVID-19 surgical patients due to restricted access to intensive or intermediate care units (ICU/IMCUs). We estimated excess surgical mortality potentially attributable to ICU/IMCUs overwhelmed by COVID-19, and any hospital learning effects between two successive pandemic waves.
METHODS: This nationwide observational study included all patients without COVID-19 who underwent surgery in France from 01/01/2019 to 31/12/2020. We determined pandemic exposure of each operated patient based on the daily proportion of COVID-19 patients among all patients treated within the ICU/IMCU beds of the same hospital during his/her stay. Multilevel models, with an embedded triple-difference analysis, estimated standardized in-hospital mortality and compared mortality between years, pandemic exposure groups, and semesters, distinguishing deaths inside or outside the ICU/IMCUs.
RESULTS: Of 1,870,515 non-COVID-19 patients admitted for surgery in 655 hospitals, 2% died. Compared to 2019, standardized mortality increased by 1% (95% CI 0.6-1.4%) and 0.4% (0-1%) during the first and second semesters of 2020, among patients operated in hospitals highly exposed to pandemic. Compared to the low-or-no exposure group, this corresponded to a higher risk of death during the first semester (adjusted ratio of odds-ratios 1.56, 95% CI 1.34-1.81) both inside (1.27, 1.02-1.58) and outside the ICU/IMCU (1.98, 1.57-2.5), with a significant learning effect during the second semester compared to the first (0.76, 0.58-0.99).
CONCLUSION: Significant excess mortality essentially occurred outside of the ICU/IMCU, suggesting that access of surgical patients to critical care was limited.
参考来源
- Duclos A, Cordier Q, Polazzi S, et al. Excess mortality among non-COVID-19 surgical patients attributable to the exposure of French intensive and intermediate care units to the pandemic. Intensive Care Med. 2023. PMID: 36840798. doi:10.1007/s00134-023-07000-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。